Epstein-Barr Virus and Gene Methylation in Gastric Cancer
Author Information
Author(s): Ryan Julie L, Jones Richard J, Kenney Shannon C, Rivenbark Ashley G, Tang Weihua, Knight Elizabeth RW, Coleman William B, Gulley Margaret L
Primary Institution: University of Rochester Medical Center
Hypothesis
The study aims to examine the role of Epstein-Barr Virus (EBV) in the dysregulation of cellular factors implicated in gastric carcinogenesis.
Conclusion
EBV alters human gene expression in ways that could contribute to the unique pathobiology of virus-associated cancer, and demethylating agents may have therapeutic potential.
Supporting Evidence
- Nearly half of the 96 human genes tested were dysregulated after EBV infection.
- Demethylation reversed EBV-mediated dysregulation for all 11 genes studied.
- Virus-related dysregulation of COX2 levels was confirmed at the protein level.
Takeaway
This study found that a virus called Epstein-Barr can change how genes work in stomach cancer cells, and using certain drugs might help fix those changes.
Methodology
Gene expression patterns were examined in EBV-negative and EBV-positive gastric cells using microarrays and PCR techniques.
Potential Biases
The study may not fully represent the effects of EBV infection in vivo due to the use of cell line models.
Limitations
Only one gastric cell line was examined, and the demethylating agent was applied for a limited duration.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website